Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation

Niklas W. Andersson, Henrik Svanstrom, Marie Lund, Bjorn Pasternak, Mads Melbye

13 Citations (Scopus)
Plum Print visual indicator of research metrics
  • Citations
    • Citation Indexes: 27
  • Captures
    • Readers: 58
see details
Original languageEnglish
JournalInternational Journal of Cardiology
Volume268
Pages (from-to)113-119
ISSN0167-5273
DOIs
Publication statusPublished - 1 Oct 2018

Keywords

  • Non-valvular atrial fibrillation
  • Direct oral anticoagulant
  • Stroke
  • Major bleeding
  • Propensity-matched comparison

Fingerprint

Dive into the research topics of 'Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation'. Together they form a unique fingerprint.

Cite this

Andersson, N. W., Svanstrom, H., Lund, M., Pasternak, B., & Melbye, M. (2018). Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation. International Journal of Cardiology, 268, 113-119. https://doi.org/10.1016/j.ijcard.2018.03.047